OptimizeRx Corporation reiterated earnings guidance for the year 2022. For the period, the company is reiterating its full year financial outlook for 2022 for net revenue to be between $62 million and $68 million, representing year-over-year growth of 1% to 11%, respectively, and gross margins to be between 59% and 62%.